RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,608,991 | +37.7% | 157,426 | -1.0% | 0.23% | +53.7% |
| Q2 2023 | $2,621,234 | -4.5% | 158,959 | +3.4% | 0.15% | -4.5% |
| Q1 2023 | $2,743,542 | -38.5% | 153,786 | +0.4% | 0.16% | -39.1% |
| Q4 2022 | $4,461,242 | +6.9% | 153,202 | -10.1% | 0.26% | +5.8% |
| Q3 2022 | $4,174,000 | +532.4% | 170,357 | +7.1% | 0.24% | +656.2% |
| Q2 2022 | $660,000 | -58.0% | 159,000 | +16.5% | 0.03% | -49.2% |
| Q1 2022 | $1,573,000 | +23.6% | 136,521 | +7.0% | 0.06% | +40.0% |
| Q4 2021 | $1,273,000 | -34.9% | 127,546 | -14.8% | 0.04% | -37.5% |
| Q3 2021 | $1,955,000 | -30.6% | 149,720 | +4.0% | 0.07% | -28.0% |
| Q2 2021 | $2,819,000 | +106.2% | 143,994 | +124.1% | 0.10% | +122.2% |
| Q1 2021 | $1,367,000 | -5.7% | 64,261 | +31.9% | 0.04% | -11.8% |
| Q4 2020 | $1,449,000 | +22.5% | 48,723 | -10.7% | 0.05% | +6.2% |
| Q3 2020 | $1,183,000 | +42.5% | 54,591 | +46.7% | 0.05% | +33.3% |
| Q2 2020 | $830,000 | -11.9% | 37,210 | -39.9% | 0.04% | -32.1% |
| Q1 2020 | $942,000 | -33.0% | 61,914 | +1.0% | 0.05% | +10.4% |
| Q4 2019 | $1,407,000 | +0.6% | 61,295 | -5.4% | 0.05% | -4.0% |
| Q3 2019 | $1,399,000 | +0.6% | 64,804 | +2.5% | 0.05% | +8.7% |
| Q2 2019 | $1,391,000 | +118.7% | 63,217 | +172.5% | 0.05% | +130.0% |
| Q1 2019 | $636,000 | – | 23,202 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |